Partner Perspectives | Fingerpaint Group
Solving Access Challenges in Today’s Market
Andy Pyfer, Brand Insights Contributor, Partner, Fingerpaint;Roshawn Blunt, Brand Insights Contributor, Managing Director of 1798, a Fingerpaint company
April 30th 2020New drug launches face more marketplace scrutiny today than a decade ago. Brand success requires not only communicating the clinical value to providers and patients, but also demonstrating the cost-effectiveness to payers in a real-world setting.
How Rare Disease Marketing Will Stretch Beyond the Patient
Laura Wilson, Brand Insights Contributor, Patient Strategy, Fingerpaint;Jonathan Romeo, Brand Insights Contributor, Brand Strategy, Fingerpaint
January 31st 2020The foundation of a strong rare disease marketing program must be built on the comprehensive knowledge of how the life-altering disease impacts all areas of a patient’s life.
